title: Response to Mahe.
authors.affiliation: 1] Tissue Oncology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia [2] Sydney Medical School, University of Sydney, Sydney, NSW, Australia [3] School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia.
authors.forename: Wendy A
authors.initials: WA
authors.lastname: Cooper
authors.affiliation: 1] Peter MacCallum Cancer Centre, Department of Medical Oncology, East Melbourne, VIC, Australia [2] University of Melbourne, Parkville, VIC, Australia.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Solomon
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*
chemical_list: D020794:Receptor Protein-Tyrosine Kinases